Bayer's Adempas gets EU approval nod
This article was originally published in Scrip
Executive Summary
Just a week after Japan's Ministry of Health, Labour and Welfare (MHLW) granted approval to Bayer Healthcare's Adempas (riociguat), the product has been given the go-ahead by the EU's CHMP.